Jan. 22, 2009 Dr. Michael Lisanti and colleagues at Thomas Jefferson University found that extended lactation protects again mammary tumor development.
Women who breastfeed for greater than two years have a significantly reduced risk of developing breast cancer later in life. It has been difficult to determine the cause of this benefit, however, due to the lack of a suitable animal model of extended lactation.
In this study, Sotgia et al demonstrated that mice deficient in caveolin 3, which is expressed in some mammary cells, had a constitutive lactation phenotype. Notably, caveolin 3-deficient mice were also protected against mammary tumor formation and lung metastases. These mice, therefore, provide a model of constitutive lactation that may be used to study the prevention or treatment of human breast cancers.
Dr. Lisanti's group suggest that "a lactation-based therapeutic strategy would provide a more natural and non-toxic approach to the development of novel anti-cancer therapies. In this regard, targeted reduction of Cav-3 levels in the mammary gland may represent a new therapeutic strategy for preventing the onset of human breast cancers."
Other social bookmarking and sharing tools:
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
- Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Menezes DW, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou J, Wang C, Pestell RG, Lisanti MP. Loss of Caveolin-3 Induces a Lactogenic Microenvironment that is Protective Against Mammary Tumor Formation. Am J Pathol, 2009, 174: 613-629
Note: If no author is given, the source is cited instead.